Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition?

  • Jossimara Polettini,

    Affiliations: Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America, Department of Pathology, Botucatu Medical School, UNESP–Univ. Estadual Paulista, Botucatu, Sao Paulo, Brazil

  • Faranak Behnia,

    Affiliation: Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America

  • Brandie D. Taylor,

    Affiliation: Department of Epidemiology & Biostatistics, Texas A&M University System Health Science Center, College Station, Texas, United States of America

  • George R. Saade,

    Affiliation: Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America

  • Robert N. Taylor,

    Affiliation: Department of Obstetrics and Gynecology, Wake Forest University, Winston Salem, North Carolina, United States of America

  • Ramkumar Menon

    Affiliation: Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America

Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition?

  • Jossimara Polettini, 
  • Faranak Behnia, 
  • Brandie D. Taylor, 
  • George R. Saade, 
  • Robert N. Taylor, 
  • Ramkumar Menon


Oxidative stress (OS)-induced senescence of the amniochorion has been associated with parturition at term. We investigated whether telomere fragments shed into the amniotic fluid (AF) correlated with labor status and tested if exogenous telomere fragments (T-oligos) could induce human and murine amnion cell senescence. In a cross-sectional clinical study, AF telomere fragment concentrations quantitated by a validated real-time PCR assay were higher in women in labor at term compared to those not in labor. In vitro treatment of primary human amnion epithelial cells with 40 μM T-oligos ([TTAGGG]2) that mimic telomere fragments, activated p38MAPK, produced senescence-associated (SA) β-gal staining and increased interleukin (IL)-6 and IL-8 production compared to cells treated with complementary DNA sequences (Cont-oligos, [AATCCC]2). T-oligos injected into the uteri of pregnant CD1 mice on day 14 of gestation, led to increased p38MAPK, SA-β-gal (SA β-gal) staining in murine amniotic sacs and higher AF IL-8 levels on day 18, compared to saline treated controls. In summary, term labor AF samples had higher telomere fragments than term not in labor AF. In vitro and in situ telomere fragments increased human and murine amnion p38MAPK, senescence and inflammatory cytokines. We propose that telomere fragments released from senescent fetal cells are indicative of fetal cell aging. Based on our data, these telomere fragments cause oxidative stress associated damages to the term amniotic sac and force them to release other DAMPS, which, in turn, provide a sterile immune response that may be one of the many inflammatory signals required to initiate parturition at term.


Signals that initiate normal labor are still unclear [1] although multitudes of putative biochemical mediators and their pathways have been suggested as initiators [2,3]. The best documented signals occur in both maternal and fetal compartments and include endocrine (Corticotrophin relasing hormone [CRH], Adrenocorticotropic hormone [ACTH], functional progesterone withdrawal), immune (leukocyte and leukotriene activation) and mechanical factors (enhanced uterine stretching and amniochorionic membrane disruption). These factors cause an inflammatory activation (mostly mediated by cytokines), and prostaglandin production to transform a quiescent myometrium to an active contractile state at term [2,48]. Pathological activation of myometrial contractility by cytokines and prostaglandins also has been implicated in spontaneous preterm birth (PTB) [911]. Identification of the critical signals and understanding their molecular mechanisms that initiate parturition is essential for reducing the risk of PTB, a major pregnancy complication.

We have proposed that fetal signals to initiate parturition arise from senescent fetal membrane cells. Senescence is characterized by irreversible growth arrest of cells and is a mechanism associated with aging [12]. Senescence of fetal cells is a natural physiologic process that occurs throughout gestation [13] and is particularly noticeable at term [13,14]. Increased senescence is likely due to enhanced oxidative stress (OS) generated by the growing fetus, uterine stretch or other still unknown factors [14]. OS-induced damage to cellular elements causes structural and functional alterations, resulting in senescence [15]. Morphologic (enlarged cells, and round and swollen organelles) and biochemical features (senescence associated β-Galactosidase [SA β-Gal], of senescence are evident in fetal membranes from women in term labor compared to term not in labor [16]. AF from term labor also had dysregulated inflammatory markers compared to gestational age-matched not in labor samples, suggesting sterile inflammation (inflammation in the absence of infectious agent) and its associated senescence associated secretory phenotype (SASP), a unique set of inflammatory markers, that include cytokines, chemokines, growth factors, matrix degrading enzymes, inhibitors and various other agionists and antagonists [16]. We posit that the inflammatory milieu generated by senescent cells [17,18] activates functional progesterone withdrawal, produces uterotonins and signals parturition. In vitro, we recapitulated these findings in primary human amnion epithelial cells from term not in labor specimens. Amniotic epithelial cells exposed to OS developed SASP via activation of p38MAPK [19] resembling such changes seen in membranes from women in term labor [14]. Therefore, it is likely that senescence inducing risk factors of PTB cause pathologic activation of senescence and SASP that lead to preterm labor.

It has been suggested that increased levels of cell-free fetal DNA in the maternal circulation, released as a result of placental senescence, can activate parturition [20]. A potential source of cell-free DNA is from the telomeres, the chromosome end caps that stabilize the genome in humans and other long-lived mammals [21]. Accordingly, we have reported that telomere length reduction occurs in fetal compartments throughout gestation, with the shortest telomeres seen in term fetal membranes, suggesting a natural in utero aging process [13]. In human cells, telomeres range from 8,000–10,000 bp in length with a single-strand TTAGGG 3’ overhangs of 100–400 bases [22,23]. This terminal triplet of guanines is highly vulnerable to OS damage and single-strand breaks in this region are more resistant to nucleotide excision repair compared to the general genome [24]. The conversion of guanine into 8-oxoguanine (8-oxoG) is the most lethal OS induced lesion and the expectedly G-rich telomeres are highly susceptible to this damage [25]. We recently reported increased OS-induced DNA damage, predominated by 8-oxoG, due to reduced base excision repair by 8-oxoG glycosylase (OGG1) in human fetal membranes [26].

Previous data demonstrated that the majority of long-lived DNA damage foci in stress-induced senescent cells colocalize with telomeres, indicating that they are major contributors to a persistent DNA damage repair (DDR) mechanism [27]. Considering that telomere sequences are particularly vulnerable to OS [28], we tested the hypothesis that senescence of the fetal membranes, physiologically at term, results in telomere fragment release into amniotic fluid. Additionally, we demonstrated that oligonucleotides mimicking the telomere overhang sequence (T-oligos) activate cellular senescence and produce inflammatory cytokines through p38MAPK in vitro and in situ in human amnion epithelial cells and in pregnant murine models, respectively.

Materials and Methods

Institutional review board approval of the study

Amniotic fluid (AF) samples used for this study were from the Nashville Birth Cohort Biobank, established to study genetic and biomarker differences contributing to racial disparity in preterm birth. Samples were collected at Centennial Medical Center Nashville, TN, USA from 2008–2011. The study protocols for recruitment and collection of AF samples were approved by the Western Institutional Review Board, Seattle, WA; the reuse of samples for preterm birth related projects was approved by the Institutional Review Board (IRB) at The University of Texas Medical Branch (UTMB), Galveston, TX, USA. The authors complied with the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects. Informed written consent was obtained from subjects prior to sample collection. Enrollment occurred at the time of admission for delivery.

Subject recruitment and phenotype definitions

In this nested cross-sectional analysis, pregnant women between the ages of 18–40 years provided amniotic samples. Term specimens were obtained from women with a gestation age ≥ 370/7 weeks; labor was defined as the presence of spontaneous, regular uterine contractions at a minimum frequency of 2 contraction/10 minutes, leading to delivery (term in labor group) and cervical dilatation. Women at term but not in labor (NIL) also were recruited. Details of this cohort and samples can be found in our other publications [2933].

Amniotic fluid sample collection

For vaginal deliveries, AF samples were collected during labor immediately before artificial rupture of the membranes by transvaginal amniocentesis of intact membranes using a 22 gauge needle through the dilated cervical os. In cases undergoing cesarean delivery, samples were collected by transabdominal amniocentesis. In order to isolate the telomere fragments from intact telomere repeat sequences from amniocytes and other cells in the AF, samples were immediately centrifuged three times at 3000 x g to remove all cells and particulate debris (amniotic sludge) [34] and supernatant aliquots were processed rapidly and stored in the dark at -80°C in filled tubes to minimize auto-oxidation during storage.

Demographic data were collected from patient interviews and clinical data were extracted from the patient medical records. Data collection included age, ethinicity, socioeconomic status (education, annual income and marital status), smoking, pre-pregnancy body mass index, and a complete medical and obstetrical history.

Quantitation of telomere fragments in amniotic fluid

The final supernatants from stored AF samples were collected for DNA isolation using a commercial kit (DNeasy Blood and Tissue Kit, Qiagen, Germantown, MD) following the manufacturer’s recommendations. The quality and concentration of extracted DNA were determined by 260/280 nm absorbance ratio (Gen5, Epoch, Bio Tek, Winooski, VT, USA), and the relative concentration of telomere fragments was analyzed using quantitative real-time PCR (qPCR). References for relative number of telomere fragments were generated by performing serial dilutions from a reference DNA sample to produce concentrations of DNA ranging from 20 to 0.625 ng/μL. Quadruplicate (for standard curves) and triplicate (for samples) PCR reactions using 5 ng DNA for each sample were carried out in a 20μL volume using 2x DNA Master SYBR Green kit (Applied Biosystems (ABI), Foster City, CA, USA) on an ABI 7500 real-time PCR machine with SDS software, version 1.3.1. Primers for telomere (tel1b, 5'-CGG TTT GTT TGG GTT TGG GTT TGG GTT TGG GTT TGG GTT-3'; and tel2b, 5'-GGC TTG CCT TAC CCT TAC CCT TAC CCT TAC CCT TAC CCT-3') were added to the final concentration of 0.2 μM. The thermal cycling profiles were as follows: 95°C for 10 min, followed by 20 cycles of 95°C for 5 s, 56°C for 10 s, and 72°C for 60 s. Template controls were included in all plate reactions. The relative number of telomere fragments in each specimen was normalized to the reference sample [2-(ΔCt(sample) – ΔCt(control) = 2-ΔΔCt] and β-Globin was used as for internal control gene.

Primary human amnion cell cultures

Fetal membrane collection.

Fetal membranes were dissected immediately after placental delivery from women undergoing elective repeat cesarean section for uncomplicated pregnancies at term, not in labor, at the John Sealy Hospital at UTMB, TX, USA. The IRB approval for discarded tissues was obtained prior to sample collection. The amnion layer was peeled from the underlying choriodecidua, washed in warm saline and small pieces (0.5 cm2) were digested twice with trypsin (1 mg/mL) and collagenase (0.5 mg/mL) for 30 minutes at 37°C. The digestion buffer was inactivated by DMEM complete media [(DMEM/F12 (Sigma-Aldrich, Saint Louis, MO, USA) supplemented with 15% fetal bovine serum (Sigma-Aldrich) and antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin, (Sigma-Aldrich)] and the cells were collected by centrifugation. Cells were counted with a hemocytometer, and 1.5–2.0K cells were seeded in 10 cm culture flasks with DMEM complete media, at 37°C in a humidified atmosphere containing 5% CO2. The purity of the epithelial cells was greater than 95%, as determined by staining with cytokeratin antibodies (Pan-Cytokeratin, Abcam, Cambridge, MA, USA, #ab80826) [35,36]. The culture media were replaced every 48h. To control for effects of replicative senescence, all experiments were performed 8–10 days after primary culture. First passage cells were exposed to 40 μM telomere overhang mimetic sequence (T-oligos, [TTAGGG]2) or 40 μM control oligonucleotides (Cont-oligos, [AATCCC]2) for 48 hours. This working concentration was based on previously reported cytotoxic and/or cytostatic effects [3740]. The oligonucleotides were purchased from Midland Certified Reagent Co. (Midland, TX, USA). Untreated cells were analyzed as a control. Results are representative from 5 independent cultures.

Cell viability assay.

Cell viability was quantified based on a fluorescence assay. The membrane-impermeable dye propidium iodide (Sigma-Aldrich, #P4864) stains the nuclei of non-viable cells with red fluorescence, whereas the nuclei of all cells are stained with membrane-permeable Hoechst 33342 dye (Invitrogen, Carlsbad, CA, USA #H1399) [41]. Confluent cultures of amnion cells growing on glass chamber slides were evaluated for cell viability after 48h-treatment using 2.0 mg/ml propidium iodide and 1.0 mg/ml Hoechst 33342 for 20 minutes at 37°C under an Olympus BX43 fluorescence microscope with a URFL-T digital camera, and QCapture Pro software (Micropublisher 6.0, Burnaby, BC, Canada).

Assessment of DNA damage

Immunofluorescence (IF) for phosphorylated (γ) histone H2AX.

In order to evaluate the activation of the DNA damage response in amnion cells, we performed IF for phosphorylated histone γ-H2AX. Cells were fixed in ethanol 95% for 10 min at RT and blocked for 1h in PBS containing 1% BSA. Primary antibody (γ-H2AX, Abcam #ab22551) was diluted in blocking buffer and incubated for 3h. The cells were washed, incubated with secondary antibody (Dye Light 488, Abcam #ab96875) for 20min at RT, washed again, counter stained with 4’-6-diamidino-2-phenylindole (DAPI) and mounted with mount media. Images were acquired and analyzed under 40x magnification.

Western Blot—p53, p38

Cultured amnion cells were lysed in RIPA lysis buffer with freshly added protease and phosphatase inhibitors (0.01%). The lysate was collected after scraping the culture plate and the insoluble material was removed by centrifugation at 10,000 rpm for 20 min at 4°C. The concentration of protein in each lysate was determined by using the BCA protein assay kit (Pierce BCA Protein Assay Kit, Thermo Scientific, Waltham, MA, USA). Equal protein (30 μg) from each sample was loaded onto a 10% SDS-PAGE gel and electrophoresed at 120 V. The resolved proteins were transferred to a PVDF membrane using the iBlot transfer apparatus (Bio-Rad Laboratories, Hercules, CA, USA). The membranes were blocked in Tris-Buffered Saline (TBS) containing 0.1% Tween 20 (TBS-T) and 5% skim milk for 2h at room temperature. Blots were incubated separately with antibodies against total p38MAPK (Cell Signaling, Danvers, MA, USA, #9212), phosphorylated (P)-p38MAPK (Cell Signaling, #9211S), p53 (Abcam, #ab1101), P-p53 (Abcam, #ab1431) or β-actin (Sigma-Aldrich, #A5441) at 4°C and shaken overnight. Blots were washed three times with TBS-T and incubated with appropriate peroxidase-conjugated IgG secondary antibody for 1h at RT. All blots were developed using chemiluminescence reagents ECL Western Blotting Detection System (Amersham Piscataway, NJ, USA), in accordance with the manufacturer’s recommendations, followed by autoradiography.

Senescence-associated β-galactosidase (SA β-gal) assay

The SA β-gal activity, a senescent cell marker [42], was evaluated using a commercial histochemical staining assay, following the manufacturer’s instructions (Senescence Cells Histochemical Staining Kit; Sigma-Aldrich). Briefly, cells cultured in chamber slides were washed twice in PBS, fixed for 6–7 min with the provided Fixation Buffer, washed again in PBS and incubated for 1h at 37°C with fresh β-gal solution. Following incubation, cells were evaluated using a standard light microscope. The number of β-gal positive cells was scored by counting at least 300 cells per representative field and expressed as percentage of total cells [41].

RNA isolation, cDNA preparation, and quantitative reverse transcription PCR

RNA was extracted from amnion cells using Direct-zol RNA Mini Prep kits (Zymo-Research, Irvine, CA, USA), according to the manufacturer’s instructions. The quality and concentration of extracted total RNA were measured by using Gen 5 Software, version 2.1 (Biotek Synergy H4 Hybrid Reader, Winooski, VT, USA) and the RNA samples (0.1 mg/mL) were subjected to reverse transcription using the High-Capacity cDNA Archive Kit (Applied Biosystems, Carlsbad, CA, USA), in accordance with the manufacturer’s instructions. The cDNA was used to quantify gene expression using TaqMan-validated primers and TaqMan MGB probes (Applied Biosystems) were used to amplify IL-6, IL-8, Toll like receptor (TLR)-9 and 16S (reference) genes (ID Hs00174131_m1, Hs00174103_m1, Hs00152973_m1 and Hs99999901_s1, respectively). The comparative 2-ΔΔCt method was used for calculating relative gene expression.

Luminex immunoassay for IL-6 and IL-8

Multiplex luminex-based immunoassays were performed for the cytokines IL-6 and IL-8 with the use of antibody-coated beads (Biosource International, Camarillo, CA, Luminex Corporation, Austin, TX, USA). Standard curves were developed with duplicate samples of known quantities of recombinant proteins that were provided by the manufacturer. Sample concentrations were determined by relating the samples absorbances to the standard curve by linear regression analysis. Concentrations below the assay detection limits (IL-6 = 5.89 pg/mL and IL-8 = 5.93 pg/mL) were considered as half of each value.

Inhibition of p38MAPK induced senescence by SB203580 (p38MAPK inhibitor)

Considering the results regarding p38MAPK expression, additional experiments were performed using SB203580, a p38MAPK inhibitor, in order to verify the influence of p38MAPK activation on senescence profiles. Primary amnion cells were seeded for 24 hours before pretreatment with 30 μM SB203580 (Sigma-Aldrich, #S8307) for 6h. Subsequently, T-oligos, Control-oligos or complete media (untreated control) were added to the cells as described above. Senescence associated β-gal staining and IL-6 and IL-8 cytokine production were analyzed as described above.

Confirmation of p53 inducibility in amnion epithelial cells

We verified the inducibility of p53 in primary amnion cells by treatment with 100 μM etoposide (Sigma-Aldrich, #E1383) for 24h. The drug was dissolved in 0.01% DMSO in DMEM complete media, and the control cells were treated with the same DMSO-media without the addition of etoposide [43]. Western blots were used to detect p53 expression.

Murine model of telomere fragment exposure

To test induction of senescence by T-oligos, in situ studies were conducted using pregnant CD-1 mice (Charles River Laboratories, Wilmington, MA, USA). Animals were shipped on day 10 of gestation and acclimated in a temperature-and humidity-controlled facility with automatically controlled 12:12 hour light and dark cycles. Mice were allowed to consume regular chow and drinking solution ad libitum. The Institutional Animal Care and Use Committee (IACUC) at the University of Texas Medical Branch at Galveston, TX, USA approved the study protocol.

On day 14 of pregnancy, the mice (n = 5/group) were subjected to mini-laparotomy and each uterine horn was injected with saline (control), 60 nM T-oligo or Cont-oligo diluted in saline, either with or without 30 μM of SB 203580 in a final volume of 150uL. The T-oligo concentration was based on previous experimental data that demonstrated senescence in tumor cells after T-oligo injections [44]. Injections were done in between 2–3 gestational sacs (those most proximal to the cervix) on the left side of gravid uteri as previously described in the infection animal model [45]. Animals were allowed to recover in a warm environment and daily monitoring. We sacrificed the animals on day 18 by carbon dioxide inhalation according to the IACUC and American Veterinary Medical Association guidelines. Fetal weight, demise/absorption was recorded. Maternal serum, AF and amniotic sacs were collected from each animal and stored at -80°C. Amniotic sacs were analyzed regarding oxidative stress marker staining (3-nitrotyrosine modified proteins, 3-NT) by immunohistochemistry, p38MAPK activation by western blot and SA β-gal by specific immunostaining (as described above). Maternal serum and AF were analyzed for IL-6 and IL-8 by Luminex assay (as described above).

Statistical analysis

Telomere fragments analyses.

We categorized the clinical pregnancies into two outcome groups (term labor and term NIL). Comparisons between outcome groups and demographic and pregnancy characteristics were made using Pearson’s Chi-Square or Fisher’s exact tests when the cell size was less than 5. For continuous variables which were non-normally distributed, Mann-Whitney test was used to test for equality of the medians. For telomere analysis, telomere fragments were transformed to the square root. Means and confidence intervals were back-transformed for reporting. Representative means and standard deviation (SD) of amplifiable telomere fragments were assessed with t-tests and p < 0.05 was used for significance.

Based on group means, standard deviation and effect size (f = 0.46), a post-hoc power analysis revealed that we had >80% power for our t-test to detect a difference in amplifiable telomere fragments between groups at a 0.05 significant level. Square root transformation of the data was used due to the skewed distribution.

Data analysis from in vitro and in situ experiments.

GraphPad Prism (version 5) software was used to calculate significant differences regarding densitometric quantitation of p38MAPK activation, percentage of SA β-gal positive cells and mRNA and protein expressions. ANOVA followed by Tukey's Multiple Comparison post-hoc test, or Kruskal-Wallis test, were used for comparison among the studied groups according to normal or non normal distributions, respectively.


Clinical demographics

We compared demographic and clinical characteristics between 50 women in term labor and 51 women at term NIL. Women in term labor had a lower median maternal age, were less likely to be married and less likely to have a gravidity >2 when compared to term NIL, while no differences were seen in the other variables between the groups (Table 1). We used samples that are gestational age matched to assure that the effect we report in this study are not impacted by gestational age differences. Gestational age for term labor and term NIL women at delivery were, respectively, 39 (1.6) and 39 (0.8) (median, IQR); p = 0.55 (Table 1).

Table 1. Demographic, obstetric and clinical characteristics of studied patients according to the pregnancy outcome.

Similarities and differences in telomere fragment levels

The mean levels of amplifiable AF telomere fragments were higher in term in labor than NIL [mean 2.4±0.2 (standard deviation SD) vs.mean 1.8±0.3; p = 0.04) (Fig 1).

Fig 1. Quantitation of telomere fragments in human amniotic fluid.

Scatter plot representing the number of telomere fragments detected in amniotic fluid from normal term not in labor (NIL) and term in labor samples. The distribution of telomere fragments significantly differs between groups (p = 0.04; t-test).

Telomere fragments are not cytotoxic to human amniotic epithelial cell cultures

Concentrations of telomere fragments circulating in AF are higher under conditions that we previously documented to be associated with increased OS and short cellular telomeres, particularly term labor [13,14]. To test our hypothesis that telomere fragments might be toxic to primary human amnion epithelial cells (Fig 2A), we incubated synthesized telomere mimetic oligonucleotides (T-oligos), with amnion cells and evaluated their viability. As shown in Fig 2B–2D, there were no differences in propidium iodide exclusion (red staining) among untreated, Cont-oligo and T-oligo treated cells, confirming their viability after 48h in culture. We interpret these findings to indicate that the subsequent results reflect experimentally induced changes that are not originating from general loss of cell membrane integrity in culture.

Fig 2. Human amniotic cells primary cultures.

(A) Immunofluorescent staining of cytokeratin positive amnion epithelial cells. Inset, a. cytokeratin positive cells and b. nuclear staining DAPI. Original magnification x40. (B-D) Cell viability. Representative fluorescence photomicrographs of merged propidium iodide and Hoechst 33342-stained amnion cells. B. Untreated cells, C. Cont-oligo treated cells and D. T-oligo treated cells. Original magnification x40. (E-G) Representative image of Western blot analysis and densitometric quantitation of p38MAPK activation in amnion cells. E. Top panel = phosphorylated (P)-p38MAPK, middle panel = total p38MAPK and bottom panel = β-actin in untreated, Cont-oligo and T-oligo treated cells, respectively. F. Quantitation of P-p38MAPK densitometry normalized to total p38MAPK. T-oligo treatment produced significant (*) increase in P-p38MAPK compared to both untreated and Cont-oligo treated cells. G. Densitometric quantitation of P-p38MAPK normalized to β-actin. Post hoc tests indicated that T-oligo treatment produced significant (*) increase in P-p38MAPK compared to untreated control, but was not significant compared to Cont-oligo treatment. (*ANOVA, p<0.05). (H) Representative image of Western blot analysis of p53 activation in human amnion cells. Top panel = P-p53, middle panel = total p53 and bottom panel = β-actin in untreated and etoposide treated amnion cells, respectively. (I-M) Senescence associated β-galactosidase (SA-β-gal) staining of amnion cells. Single blue stained cells indicate positive β-gal activity. I. Untreated cells, J. Cont-oligo treated cells, K. T-oligo treated cells and L. T-oligo+SB203580 (p38MAPK inhibitor) treated cells. M. Quantification of the positive SA-β-gal cells. Bar graphs represent the differences in the percentage of SA-β-gal staining cells in each group. T-oligo treatment produced a significant increase (*) in the number of senescing cells, which was inhibited by SB203580 treatment. (*ANOVA, p<0.001). (N-Q) Senescence associated sterile inflammation in amnion cells. N. Relative quantification of IL-6 mRNA (p>0.05), O. Relative quantification of IL-8 mRNA in amnion cells (*p = 0.02), P. Protein concentration of IL-6 in conditioned media (*p<0.0001), and Q. Protein concentration of IL-8 in conditioned media (*p = 0.001). The production of IL-8 and IL-6 was inhibited by simultaneous treatment with SB203580. * ANOVA, T-oligo treated samples significantly higher compared with untreated, cont-oligo or T-oligo+SB samples. (Results are representative from 5 amnion cultures/ group. Telomere mimetic overhang sequence (T-oligo, [TTAGGG]2); control oligonucleotides (Cont-oligo, [AATCCC]2); untreated cells (Control CTR).

Amnion cell p38MAPK activation by T-oligo treatment

Previous reports from our lab indicated that amnion cells under oxidative stress develop senescence features primarily through p38MAPK activation [19], similar to those seen in human liver cancer cells [46]. As shown in Figs 2E–2G, T-oligo treatment induced higher P-p38MAPK than unstimulated controls (p = 0.02, ANOVA), but statistically significant differences were not achieved between T-oligo and Cont-oligo treated cells. Active (phosphorylated) p53 (P-p53) was not seen in amnion cells after treatment with T- or Cont-oligos. This raises a question of p53 inducibility in primary human amnion cells, as we have not seen p53 activation using any stimulants that cause OS and senescence. However, we did verify that p53 could be activated in these cells with 100 μM etoposide treatment for 24 h, a well-documented activator of the anticancer agent p53 tumor suppressor. (Fig 2H).

T-oligos induce senescence phenotype and increase sterile inflammatory markers in human amnion epithelial cell cultures

Senescence was tested by SA β-gal staining after treatment with either T- or Cont-oligos. T-oligo treatment resulted in 1.7- and 1.6- fold increases in SA β-gal positive cells compared to Cont-oligo and untreated cells respectively (p = 0.004) (Fig 2I–2K). Although, we noticed some p38MAPK activation after Cont-oligo treatment, it did not result in development of senescence phenotype. To verify that senescence activation was mediated by p38MAPK, incubation with the p38 inhibitor, SB203580, was performed. As shown in Fig 2L, co-treatment with SB203580 decreased SA-β-gal positive cells compared to T-oligo treatment alone. The data are summarized in Fig 2M.

Senescence associated secretory phenotype (SASP) activation

Inflammatory activation in senescing cells can modify the cellular environment. The expression of two inflammatory cytokines, interleukin (IL)-6 and IL-8, was studied in response to T-oligo treatment. A slight increase in IL-6 mRNA expression was noted, but did not reach statistical significance (Fig 2N), while IL-8 gene expression was significantly stimulated in T-oligo treated cells relative to Cont-oligo or untreated cultures (Fig 2O). Co-treatment with SB203580 significantly reduced IL-8 expression, confirming p38MAPK mediation. We further verified the release of IL-6 and IL-8 proteins from treated cells. Both cytokine levels were significantly higher following T-oligo treatment compared to all other groups, and levels in the conditioned media were reduced to untreated concentrations when co-incubated with SB203580 (Fig 2P and 2Q).

Evidence of γ-H2AX formation

With the purpose of demonstrating the activation of DNA damage repair, we performed immunofluorescence staining of phosphorylated (γ)-H2AX formation at so-called DNA damage foci (DDF). We found the DDF to be more pronounced in cells treated with T-oligo compared to untreated cells (Fig 3A), verifying more DNA repair activation.

Fig 3. DNA damage foci and Toll like receptor (TLR)-9 expression in human amnion cells.

(A) Immunofluorescence staining of phosphorylated (γ) H2AX, a marker for DNA damage response activation. Top panel = T-oligo treated amnion cells, bottom panel = untreated cells. Left panel = γH2AX. Right panel = merged images with DAPI nuclear stain. The bright nuclear dots represent DNA damage foci and are more pronounced in cells treated with T-oligo. (B) Relative quantification of TLR-9 mRNA expression in amnion cells in the studied groups, untreated cells, Cont-oligo and T-oligo treated cells, respectively. Box plots represent the quantification relative to endogenous 16S RNA. Kruskal-Wallis test, p>0.05.(control oligonucleotides (Cont-oligo, [AATCCC]2); Telomere mimetic overhang sequence (T-oligo, [TTAGGG]2).

TLR-9 expression

In order to address a possible mechanistic pathway by which T-oligos activate intracellular signaling, we quantified TLR-9 mRNA. TLR-9 is known to trigger maternal immune cells activation in response to placenta-derived DNA [47]. However, we did not observe any difference in TLR-9 expression in amnion cells treated with T-oligos compared to controls (untreated and Cont-oligo samples) (Fig 3B).

T-oligos induce fetal membrane senescence in pregnant mice

In order to validate our findings in an in vivo model, T-oligos were injected into the intrauterine compartment of pregnant CD-1 mice on day 14 of gestation. Specimens of amniotic fluid and amniotic sac were collected after sacrificing the dams on day 18. Table 2 depicts the descriptive general data regarding studied animals according to the treatment groups. There were no significant differences regarding placenta weight, animal or pup weight among the studied groups. The numbers of fetal demises and/or resorptions were significantly higher in T-oligo treated animals compared to vehicle (saline), Cont-oligo and T-oligo cotreatment with SB203580 (p = 0.001); however, preterm delivery was not observed in the studied animals. We cannot rule out a possible effect on late preterm delivery, as the injections were performed at ~70% of the colony gestational period and sacrifice was performed on day 18.

Table 2. Descriptive data from studied CD-1 pregnant mice according to treatments groups (n = 5 animals/group): Saline, Cont-Oligo, T-oligo and T-oligo co-treatment with SB203580.

Evidence of OS induction in murine fetal membranes by T-oligos

In animals treated with vehicle (saline) or Cont-oligos, microscopic examination of the fetal membranes showed minimal evidence of OS, as expected in healthy metabolizing tissues (Fig 4A and 4B). However, we observed intense staining of 3-nitrotyrosine (3-NT) modified proteins confirming OS induced by T-oligos (Fig 4C). Co-treatment with T-oligos and SB203580 reduced the 3-NT staining intensity (Fig 4D).

Fig 4. Animal models of T-oligo induced senescence.

(A-D) Representative image of 3-nitrotyrosine (3-NT) modified proteins, an oxidative stress marker, in murine fetal membranes. Intrauterine injection of pregnant CD-1 mice were performed with either: A. Saline, B. Cont-oligo, C. T-oligo and D. T-oligo+SB23580 (p38MAPK inhibitor). (E-G) Representative image of Western blot analysis and densitometric quantitation of p38MAPK activation in murine amniotic sac. E. Top panel = phosphorylated (P)-p38MAPK, middle panel = total p38MAPK and bottom panel = β-actin in Cont-oligo, saline, T-oligo+SB203580 (p38MAPK inhibitor) and T-oligo treated mice, respectively. F. Densitometric quantitation P-p38MAPK normalized to total p38MAPK in amniotic sac tissue or G. normalized to β-actin. T-oligo treatment produced a significant (*) increase in P-p38MAPK compared to saline and Cont-oligo treated groups. The co-treatment of T-oligo and SB203580 showed similar results to controls (saline and Cont-oligo). (*ANOVA, p<0.05). Results are representative from 3 animals/ group. (Telomere mimetic overhang sequence (T-oligo, [TTAGGG]2); control oligonucleotides (Cont-oligo, [AATCCC]2).

T-oligos activate p38MAPK in murine fetal membranes

As shown in Fig 4E–4G, T-oligo-injected mice showed increased P-p38MAPK in the amniotic sac compared to saline, which was reduced to control levels in animals simultaneously treated with SB203580.

T-oligos cause senescence of murine amnion

The senescence marker SA β-gal was evaluated histochemically in the mouse amniotic sacs. Intense blue staining representing senescent cells was observed particularly within the amnion epithelium of the membranes after T-oligo injection, compared to controls (saline and Cont-oligo) and T-oligo co-treatment with SB203580 (Fig 5A–5D).

Fig 5. Senescence and inflammation induced by T-oligos in CD-1 pregnant mice.

(A-D) Senescence associated β-galactosidase (SA-β-gal) staining of murine amniotic sac. Single blue stained cells indicate β-gal activity. A. saline, B. Cont-oligo, C. T-oligo and D. T-oligo+SB203580 (p38MAPK inhibitor) treated mice. SA-β-gal staining is pronounced in T-oligo treated mice. (E) Concentration of interleukin (IL)-8 protein in murine amniotic fluid. Higher levels of IL-8 were found in T-oligo treated animals compared to controls (saline and Cont-oligo). The production of IL-8 was inhibited by simultaneous treatment with SB203580. (*ANOVA, p<0.05). Results are representative from 3 animals/ group. (Telomere mimetic overhang sequence (T-oligo, [TTAGGG]2); control oligonucleotides (Cont-oligo, [AATCCC]2).

T-oligos increase biomarkers of sterile inflammation, indicators of SASP

The activation of sterile inflammation by T-oligos, as a result of amniotic sac senescence, was examined by measuring maternal serum and amniotic fluid cytokine levels in the mouse model. Amniotic fluid from animals injected with T-oligos manifested increased concentrations of all evaluated cytokines (IL-6 and IL-8), however, only IL-8 reached statistical significance (Fig 5E). Co-treatment with SB203580 decreased cytokine concentrations. No differences in cytokine levels were observed in maternal serum samples from the same dams.


The initiation of parturition is a complex process, whose precise signals remain unclear. Several systems maintain pregnancy through homeostatic balance including the endocrine, nervous, immune, hematological, microbiome, matrix metabolism and electro-physiological; antagonism of any of these tends to promote labor [2,7,9,4850]. Breakdown of these balanced systems leads to cervical ripening, proteolysis, weakening and rupture of the fetal membranes and myometrial contraction leading to parturition [4,5]. Besides the well reported endocrine initiators, two general effectors of term parturition are oxidative stress and sterile inflammation, likely resulting from the augmented metabolic demands and depleted antioxidant reserves of the growing fetus [11,49,51]. This report opens a novel inquiry into the role of OS in the physiology of human parturition. The search for parturition triggers and prior data led us to hypothesize that OS at term signals fetal maturity and physiological aging of the fetal membranes, causing telomere shortening and sterile inflammation resulting in parturition [14,19,51]. This study provides insights into the telomere-dependent mechanism of senescence and inflammatory activation. The principal findings from this study are as follows: 1) The concentration of telomere fragments was higher in term labor than in term NIL samples. 2) T-oligos, that mimic shed telomeres, induced primary amnion epithelial cell senescence in vitro through the activation of p38MAPK and SASP, manifested by increased SA β-Gal and IL-8 gene and protein expression. Each of these steps can be mitigated using a p38MAPK inhibitor. 3) T-oligos caused murine fetal membrane OS, p38MAPK-mediated senescence and sterile inflammation (also reflected by elevated IL-8 concentrations). OS and cellular damage occur persistently during feto-placental growth [49,52,53], while cellular antioxidant proteins and repair responses prevent or minimize these damages, to avoid development of pathology. Diminished antioxidant capacity, or overwhelming OS, compromise tissue function and integrity and prompt aging [54]. Based on these principles, we propose a novel pathway whereby OS-induced DNA damage and telomere shortening in the fetal membranes accelerate senescence-associated inflammation, which acts as a fetal signal for parturition. In support of this hypothesis, OS related risk factors (e.g., cigarette smoking and low grade infection) contribute to telomere-dependent premature aging and inflammation as seen in a subset of early PTB and pPROM cases [51].

Do telomere fragments trigger parturition?

The dose of telomere fragments used in our in vitro and in situ studies or design of our study did not demonstrate that telomere fragments can induce labor; instead, the telomere fragments presence is brought up as a possible stimulator of partiturion signals, since a feedback loop they cause oxidative stress associated damages to the term amniotic sac and forces them to release other Damage Associated Molecular Patterns (DAMPs) and SASP factors. We believe that this is one of the many mechanisms that can force amnion membrane to undergo further damage and send signals to the neighboring layers to initiate parturition process. These signals can force changes in decidua (activation of leukocytes) and myometrium (functional progesterone withdrawal). Telomere reduction is a natural consequence of repeated cell division [55]. Chronic OS increases the rate of telomere shortening and reduces a cell’s replicative life span [56,57]. Telomere shortening was previously observed in fetal leukocytes and placental membranes from term and pPROM pregnancies [13]. In line with this, here we demonstrate that more telomere fragments are shed into the amniotic fluid in term labor, compared to NIL subjects. In vitro, telomere shortening and replicative senescence can be accelerated using OS inducers like cigarette smoke [41], which exerts its effects through p38MAPK activation in amnion cells [19]. We suggest that the differences in cases of term labor vs. NIL status represents a buildup of OS mediators, inducing a senescent state. Premature senescence also can be induced by telomere-independent mechanisms [58].

Telomere shortening, sensed as DNA damage, can lead to further senescence by phosphorylation of histone H2AX (γ-H2AX), a highly conserved histone family member that encodes a DNA repair and transcription regulator [59,60]. To confirm that telomere fragments might induce DNA damage in isolated amnion cells, we tested the phosphorylation of H2AX. T-oligos activated DNA damage repair by γ-H2AX expression at so-called DNA damage foci (DDF) [61]. DDF, therefore, could be a surrogate for oxidative stress-induced telomere shortening in feto-placental tissues as previously reported in certain pathologic pregnancies [13,62,63].

DNA oligonucleotides homologous to the telomere 3′ overhang (T-oligos) have been studied in several cancer cell lines as a mechanism of cellular arrest and, consequently, represent new anti-cancer therapeutic opportunities [40,44,64,65]. However, their specific cytotoxic effects depend on cell type and environment. T-oligos induced senescence activation in human breast carcinoma [66], lung cancer [67] and prostate cancer [68] cells, while normal mammary epithelial cells [66] and human and murine lymphocytes [69] failed to show senescence under T-oligo treatment. Cell and tissue specificity are seen in pathways and responses [70]. Some senescent cells exhibit p53 activation [71], which has long been considered a key T-oligo signaling mechanism [37,39,72]. Senescence is triggered through multiple pathways; the p53 pathway in particular is known to accelerate aging in mammals [73,74]. During pregnancy, premature decidual senescence in mice with conditional deletion of maternal uterine p53 (p53d/d) was associated with PTB [75,76]. Moreover, cells from diverse tissue types lacking functional p53 undergo cell cycle arrest and senescence [69]. p53 activation was not evident in human amnion or murine fetal membrane cells exposed to T-oligos in our experiments; however, etoposide treatment verified that p53 is inducible in human amnion cells. Etoposide acts as pro-oxidant on intracellular thiols in cells, but the phenoxyl radicals formed from etoposide neither trigger phosphatidylserine (apoptosis-associated molecule) oxidation and externalization, nor do they induce lipid peroxidation. Instead, etoposide acts as an antioxidant against H2O2-induced phospholipid peroxidation in HL-60 cells [77,78]. These data indicate that the etoposide effect in our cells is not related to OS induction. Studies also show that p38MAPK activation represents an alternate senescence mechanism [46,65,7981]. Intravenous administration of T-oligos rescued mice from a fatal inoculum of human breast cancer [66] and lung cancer cells treated with T-oligos showed reduced tumor volume through senescence pathways that are not dependent on p53 (56). Accordingly, our previous results indicated that p38MAPK triggers senescence in oxidatively stressed human fetal membranes and amnion epithelial cells [14,19]. Furthermore, attenuation of inflammatory cytokines after p38MAPK inhibitor treatment confirms the primacy of this pathway in the generation of sterile inflammation following T-oligo treatment in fetal cells and tissues.

The p38MAPK pathway is a major network of inflammation and stress responses [82] and in pregnancy, mediates IL-1β-induced MMP-9 in the fetal membranes [83], leading to labor. Recent findings from our laboratory reinforce the participation of p38MAPK in adverse pregnancy outcomes in vitro and in vivo [14,19]. Three p38 isoforms (α, χ and δ) activate distinct downstream cascades leading to DNA damage responses, whereby only p38δ is reported to be p53- and p16-independent [82]. However, the SB203580 inhibitor, which effectively reverses the senescence phenotype in our models, is believed to be selective for the p38 α and χ proteins. We did not explore the specific p38 isoforms expressed in amnion cells, hence we cannot discard the hypothesis that multiple p38δ isoforms might be activated in our cells.

Previous experiments using human breast carcinoma cells showed that T-oligos are efficiently taken up by cells within 30 to 60 minutes after in vitro administration and localize to the nucleus [66], where they are inherently more stable than non-G-quadruplex structures [84]. The Toll like receptor (TLR)-9 is a candidate receptor for T-oligo uptake, as it senses microbial DNA and endogenous cell-free-DNA [85,86]. However, we did not observe any difference in TLR-9 expression in amnion cells treated with T-oligos compared to controls (untreated and Cont-oligo samples). Thus, further experiments are needed to address the specific mechanism by which telomere fragments activate intracellular signaling in fetal cells.

Our data indicate that in addition to telomere shortening caused by ROS, the intracellular release of telomere fragments contributes to senescence of amnion cells via p38MAPK activation. The telomere fragments themselves can amplify fetal cell senescence triggering an inflammatory cytokine signature (SASP), which, in turn, can activate uterotonins and promote parturition. Activation of this axis prematurely, for example by excessive OS, may trigger preterm labor. A better understanding of the pathways activated by telomere fragments, their biochemistry and their contribution to fetal membrane senescence should contribute to the design of more effective labor assessment (perhaps including PTB risk), and direct diagnostic and therapeutic interventions for labor induction or prevention.


Authors acknowledge support by all the staff from the Maternal-Fetal Medicine and Perinatal Research Laboratory, University of Texas Medical Branch at Galveston (UTMB), TX, USA.

Author Contributions

Conceived and designed the experiments: RM JP. Performed the experiments: JP FB RM. Analyzed the data: JP BDT RM. Contributed reagents/materials/analysis tools: RM GS RNT. Wrote the paper: JP FB BDT RNT RM.


  1. 1. Romero R, Dey SK, Fisher SJ. Preterm labor: One syndrome, many causes. Science. 2014;345: 760–765. doi: 10.1126/science.1251816. pmid:25124429
  2. 2. Kamel RM. The onset of human parturition. Arch Gynecol Obs. 2010;281: 975–982. doi: 10.1007/s00404-010-1365-9.
  3. 3. Norman JE, Bollapragada S, Yuan M, Nelson SM. Inflammatory pathways in the mechanism of parturition. BMC Pregnancy Childbirth. 2007;7 Suppl 1: S7. doi: 10.1186/1471-2393-7-S1-S7. pmid:17570167
  4. 4. Peltier MR. Immunology of term and preterm labor. Reprod Biol Endocrinol. 2003;1: 122. doi: 10.1186/1477-7827-1-122. pmid:14651749
  5. 5. Orsi NM, Tribe RM. Cytokine networks and the regulation of uterine function in pregnancy and parturition. J Neuroendocrinol. 2008;20: 462–469. doi: 10.1111/j.1365-2826.2008.01668.x. pmid:18266939
  6. 6. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med. 1995;1: 460–463. doi: 10.1038/nm0595-460. pmid:7585095
  7. 7. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol. 2008;79: 50–57. doi: 10.1016/j.jri.2008.04.002. pmid:18550178
  8. 8. Pawelec M, Pałczyński B, Krzemieniewska J, Karmowski M, Koryś J, Lątkowski K, et al. Initiation of preterm labor. Adv Clin Exp Med. 2013;22: 283–288. pmid:23709385
  9. 9. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG. 2006;113: 17–42. doi: 10.1111/j.1471-0528.2006.01120.x. pmid:17206962
  10. 10. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371: 75–84. doi: 10.1016/S0140-6736(08)60074-4. pmid:18177778
  11. 11. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF, Petraglia F. Inflammation and pregnancy. Reprod Sci. 2009;16: 206–215. doi: 10.1177/1933719108329095. pmid:19208789
  12. 12. Campisi J, d’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8: 729–40. doi: 10.1038/nrm2233. pmid:17667954
  13. 13. Menon R, Yu J, Basanta-Henry P, Brou L, Berga SL, Fortunato SJ, et al. Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS One. 2012;7: e31136. doi: 10.1371/journal.pone.0031136. pmid:22348044
  14. 14. Menon R, Boldogh I, Hawkins HK, Woodson Michael Polettini J, Syed TA, Fortunato SJ, et al. Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro. Am J Pathol. American Society for Investigative Pathology; 2014;184: 1740–1751. doi: 10.1016/j.ajpath.2014.02.011. pmid:24832021
  15. 15. Brandl A, Meyer M, Bechmann V, Nerlich M, Angele P. Oxidative stress induces senescence in human mesenchymal stem cells. Exp Cell Res. Elsevier Inc.; 2011;317: 1541–1547. doi: 10.1016/j.yexcr.2011.02.015. pmid:21376036
  16. 16. Behnia F, Taylor B, Woodson M, Hawkins H, Kacerovsky M, Fortunato S, et al. Chorioamniotic membrane senescence: A signal for parturition? AJOG. 2015; in press. doi: 10.1016/j.ajog.2015.05.041. . [Epub ahead of print]
  17. 17. Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci. 2011;124: 68–81. doi: 10.1242/jcs.071340. pmid:21118958
  18. 18. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol. 2011;192: 547–556. doi: 10.1083/jcb.201009094. pmid:21321098
  19. 19. Menon R, Boldogh I, Urrabaz-Garza R, Polettini J, Syed TA, Saade GR, et al. Senescence of primary amniotic cells via oxidative DNA damage. PLoS One. 2013;8: e83416. doi: 10.1371/journal.pone.0083416. pmid:24386195
  20. 20. Phillippe M. Cell-free fetal DNA-a trigger for parturition. N Engl J Med. 2014;370: 2534–2536. doi: 10.1056/NEJMcibr1404324. pmid:24963574
  21. 21. Morgan CC, Mc Cartney AM, Donoghue MT a, Loughran NB, Spillane C, Teeling EC, et al. Molecular adaptation of telomere associated genes in mammals. BMC Evol Biol. BMC Evolutionary Biology; 2013;13: 251. doi: 10.1186/1471-2148-13-251. pmid:24237966
  22. 22. Blackburn EH. Switching and signaling at the telomere. Cell. 2001;106: 661–673. pmid:11572773 doi: 10.1016/s0092-8674(01)00492-5
  23. 23. Stewart S a, Ben-Porath I, Carey VJ, O’Connor BF, Hahn WC, Weinberg R a. Erosion of the telomeric single-strand overhang at replicative senescence. Nat Genet. 2003;33: 492–496. doi: 10.1038/ng1127. pmid:12652299
  24. 24. Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27: 339–344. pmid:12114022 doi: 10.1016/s0968-0004(02)02110-2
  25. 25. Rhee DB, Ghosh A, Lu J, Bohr VA, Liu Y. Factors that influence telomeric oxidative base damage and repair by DNA glycosylase OGG1. DNA Repair (Amst). 2011;10: 34–44. doi: 10.1016/j.dnarep.2010.09.008.
  26. 26. Menon R, Polettini J, Syed TA, Saade GR, Boldogh I. Expression of 8-oxoguanine glycosylase in human fetal membranes. Am J Reprod Immunol. 2014;72: 75–84. doi: 10.1111/aji.12220. pmid:24589083
  27. 27. Hewitt G, Jurk D, Marques F, Correia-Melo C, Hardy T, Gackowska A, et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun. 2012;3: 708. doi: 10.1038/ncomms1708. pmid:22426229
  28. 28. Xu Z, Duc KD, Holcman D, Teixeira MT. The length of the shortest telomere as the major determinant of the onset of replicative senescence. Genetics. 2013;194: 847–857. doi: 10.1534/genetics.113.152322. pmid:23733785
  29. 29. Fortunato SJ, Menon R, Velez DR, Thorsen P, Williams SM. Racial disparity in maternal-fetal genetic epistasis in spontaneous preterm birth. Am J Obstet Gynecol. 2008;198: 666.e1–666.e–10. doi: 10.1016/j.ajog.2008.02.003.
  30. 30. Menon R, Williams SM, Fortunato SJ. Amniotic fluid interleukin-1beta and interleukin-8 concentrations: racial disparity in preterm birth. Reprod Sci. 2007;14: 253–259. doi: 10.1177/1933719107301336. pmid:17636239
  31. 31. Menon R, Velez DR, Morgan N, Lombardi SJ, Fortunato SJ, Williams SM. Genetic regulation of amniotic fluid TNF-alpha and soluble TNF receptor concentrations affected by race and preterm birth. Hum Genet. 2008;124: 243–253. doi: 10.1007/s00439-008-0547-z. pmid:18807256
  32. 32. Menon R, Fortunato SJ, Edwards DRV, Williams SM. Association of genetic variants, ethnicity and preterm birth with amniotic fluid cytokine concentrations. Ann Hum Genet. 2010;74: 165–183. doi: 10.1111/j.1469-1809.2010.00562.x. pmid:20369436
  33. 33. Menon R, Velez DR, Simhan H, Ryckman K, Jiang L, Thorsen P, et al. Multilocus interactions at maternal tumor necrosis factor-alpha, tumor necrosis factor receptors, interleukin-6 and interleukin-6 receptor genes predict spontaneous preterm labor in European-American women. Am J Obstet Gynecol. 2006;194: 1616–1624. doi: 10.1016/j.ajog.2006.03.059. pmid:16731080
  34. 34. Pedro KJ, Espinoza J, Romero R, Gonçalves LF, Nien JK, Soto E, et al. Clinical significance of the presence of amniotic fluid “sludge” in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obs Gynecol. 2007;30: 706–714. doi: 10.1002/uog.4081
  35. 35. Erkhembaatar LO, Kotani T, Sumigama S, Tsuda H, Mano Y, Hua L, et al. Increased expression of sphingosine kinase in the amnion during labor. Placenta. Elsevier Ltd; 2013;34: 353–359. doi: 10.1016/j.placenta.2013.01.014. pmid:23462226
  36. 36. Moore RM, Silver RJ, Moore JJ. Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. Placenta. 2003;24: 173–180. pmid:12566244 doi: 10.1053/plac.2002.0886
  37. 37. Lee MS, Yaar M, Eller MS, Rünger TM, Gao Y, Gilchrest BA. Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage. J Dermatol Sci. 2009;56: 154–162. doi: 10.1016/j.jdermsci.2009.08.008. pmid:19906512
  38. 38. Marwaha V, Chen Y-H, Helms E, Arad S, Inoue H, Bord E, et al. T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. J Biol Chem. 2005;280: 32379–32388. doi: 10.1074/jbc.M503245200. pmid:16046401
  39. 39. Li G-Z, Eller MS, Firoozabadi R, Gilchrest B a. Evidence that exposure of the telomere 3’ overhang sequence induces senescence. Proc Natl Acad Sci U S A. 2003;100: 527–31. doi: 10.1073/pnas.0235444100. pmid:12515865
  40. 40. Pitman RT, Wojdyla L, Puri N. Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma. Oncotarget. 2013;4: 761–771. pmid:23800953 doi: 10.18632/oncotarget.1047
  41. 41. Yu AL, Birke K, Burger J, Welge-Lussen U. Biological effects of cigarette smoke in cultured human retinal pigment epithelial cells. PLoS One. 2012;7: e48501. doi: 10.1371/journal.pone.0048501. pmid:23155386
  42. 42. Harbo M, Koelvraa S, Serakinci N, Bendix L. Telomere dynamics in human mesenchymal stem cells after exposure to acute oxidative stress. DNA Repair (Amst). 2012;11: 774–779. doi: 10.1016/j.dnarep.2012.06.003.
  43. 43. Pan D, Marcato P, Ahn D-G, Gujar S, Pan L-Z, Shmulevitz M, et al. Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis. PLoS One. 2013;8: e54006. doi: 10.1371/journal.pone.0054006. pmid:23342061
  44. 44. Puri N, Pitman RT, Mulnix RE, Erickson T, Iness AN, Vitali C, et al. Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides. Cancer Lett. 2014;343: 14–23. doi: 10.1016/j.canlet.2013.09.010. pmid:24041868
  45. 45. Uchida K, Nakahira K, Mimura K, Shimizu T, De Seta F, Wakimoto T, et al. Effects of Ureaplasma parvum lipoprotein multiple-banded antigen on pregnancy outcome in mice. J Reprod Immunol. 2013;100: 118–127. doi: 10.1016/j.jri.2013.10.001. pmid:24238827
  46. 46. Lamy E, Herz C, Lutz-Bonengel S, Hertrampf A, Márton M-R, Mersch-Sundermann V. The MAPK pathway signals telomerase modulation in response to isothiocyanate-induced DNA damage of human liver cancer cells. PLoS One. 2013;8: e53240. doi: 10.1371/journal.pone.0053240. pmid:23382840
  47. 47. Hahn S, Giaglis S, Buser A, Hoesli I, Lapaire O, Hasler P. Cell-free nucleic acids in (maternal) blood: any relevance to (reproductive) immunologists? J Reprod Immunol. 2014;104–105: 26–31. doi: 10.1016/j.jri.2014.03.007. pmid:24815811
  48. 48. Seol H-J, Oh M-J, Lim J-E, Jung N-H, Yoon S-Y, Kim H-J. The role of CD4+CD25 bright regulatory T cells in the maintenance of pregnancy, premature rupture of membranes, and labor. Yonsei Med J. 2008;49: 366–371. doi: 10.3349/ymj.2008.49.3.366. pmid:18581584
  49. 49. Cindrova-Davies T, Yung H-W, Johns J, Spasic-Boskovic O, Korolchuk S, Jauniaux E, et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol. American Society for Investigative Pathology; 2007;171: 1168–1179. doi: 10.2353/ajpath.2007.070528. pmid:17823277
  50. 50. Ganu R, Ma J, Aagaard KM. The role of microbial communities in parturition: Is there evidence of association with preterm birth and perinatal morbidity and mortality? Am J Perinatol. 2013;30: 613–624. doi: 10.1055/s-0032-1329693. pmid:23161352
  51. 51. Menon R. Oxidative stress damage as a detrimental factor in preterm birth pathology. Front Immunol. 2014;5: 1–14. doi: 10.3389/fimmu.2014.00567
  52. 52. Watanabe K, Mori T, Iwasaki A, Kimura C, Matsushita H, Shinohara K, et al. Increased oxygen free radical production during pregnancy may impair vascular reactivity in preeclamptic women. Hypertens Res. Nature Publishing Group; 2013;36: 356–360. doi: 10.1038/hr.2012.208. pmid:23324862
  53. 53. Pereira AC, Martel F. Oxidative stress in pregnancy and fertility pathologies. Cell Biol Toxicol. 2014;30: 301–312. doi: 10.1007/s10565-014-9285-2. pmid:25030657
  54. 54. Campisi J, Vijg J. Does damage to DNA and other macromolecules play a role in aging? If so, how? Journals Gerontol—Ser A Biol Sci Med Sci. 2009;64: 175–178. doi: 10.1093/gerona/gln065.
  55. 55. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973;41: 181–190. doi: 10.1016/0022-5193(73)90198-7. pmid:4754905
  56. 56. Von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann N Y Acad Sci. 2000;908: 99–110. pmid:10911951 doi: 10.1111/j.1749-6632.2000.tb06639.x
  57. 57. Von Zglinicki T, Pilger R, Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med. 2000;28: 64–74. doi: 10.1016/S0891-5849(99)00207-5. pmid:10656292
  58. 58. Ramirez RD, Herbert B-S, Vaughan MB, Zou Y, Gandia K, Morales CP, et al. Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells. Oncogene. 2003;22: 433–444. doi: 10.1038/sj.onc.1206046. pmid:12545164
  59. 59. Ohtani N, Hara E. Roles and mechanisms of cellular senescence in regulation of tissue homeostasis. Cancer Sci. 2013;104: 525–530. doi: 10.1111/cas.12118. pmid:23360516
  60. 60. d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003;426: 194–198. doi: 10.1038/nature02118. pmid:14608368
  61. 61. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: Causal or correlative? Nucleic Acids Res. 2007;35: 7417–7428. doi: 10.1093/nar/gkm681. pmid:17913751
  62. 62. Biron-Shental T, Sukenik-Halevy R, Sharon Y, Goldberg-Bittman L, Kidron D, Fejgin MD, et al. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2010;202: 381.e1–7. doi: 10.1016/j.ajog.2010.01.036. pmid:20350645
  63. 63. Hallows SE, Regnault TRH, Betts DH. The long and short of it: the role of telomeres in fetal origins of adult disease. J Pregnancy. 2012;2012: 638476. doi: 10.1155/2012/638476. pmid:23094159
  64. 64. Sarkar S, Faller D V. Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis. Nucleic Acid Ther. 2013;23: 167–174. doi: 10.1089/nat.2012.0401. pmid:23634944
  65. 65. Rankin AM, Sarkar S, Faller D V. Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells. J Cell Physiol. 2012;227: 2586–2594. doi: 10.1002/jcp.22997. pmid:21898405
  66. 66. Yaar M, Eller MS, Panova I, Kubera J, Wee LH, Cowan KH, et al. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res. 2007;9: R13. doi: 10.1186/bcr1646. pmid:17257427
  67. 67. Klungland A, Bjelland S. Oxidative damage to purines in DNA: role of mammalian Ogg1. DNA Repair (Amst). 2007;6: 481–488. doi: 10.1016/j.dnarep.2006.10.012.
  68. 68. Gnanasekar M, Thirugnanam S, Zheng G, Chen A, Ramaswamy K. T-oligo induces apoptosis in advanced prostate cancer cells. Oligonucleotides. 2009;19: 287–292. doi: 10.1089/oli.2009.0179. pmid:19642913
  69. 69. Longe HO, Romesser PB, Rankin AM, Faller D V, Eller MS, Gilchrest B a, et al. Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer. 2009;124: 473–482. doi: 10.1002/ijc.23946. pmid:19003960
  70. 70. Rankin AM, Faller D V, Spanjaard R a. Telomerase inhibitors and “T-oligo” as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity. Anticancer Drugs. 2008;19: 329–338. doi: 10.1097/CAD.0b013e3282f5d4c2. pmid:18454043
  71. 71. Itahana K, Dimri G, Campisi J. Regulation of cellular senescence by p53. Eur J Biochem. 2001;268: 2784–2791. pmid:11358493 doi: 10.1046/j.1432-1327.2001.02228.x
  72. 72. Li GZ, Eller MS, Hanna K, Gilchrest BA. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res. 2004;301: 189–200. doi: 10.1016/j.yexcr.2004.08.019. pmid:15530855
  73. 73. Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T, et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 2004;18: 306–319. doi: 10.1101/gad.1162404. pmid:14871929
  74. 74. Edwards MG, Anderson RM, Yuan M, Kendziorski CM, Weindruch R, Prolla T a. Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics. 2007;8: 80. doi: 10.1186/1471-2164-8-80. pmid:17381838
  75. 75. Cha J, Hirota Y, Dey SK. Sensing senescence in preterm birth. Cell Cycle. 2012;11: 205–206. doi: 10.4161/cc.11.2.18781. pmid:22189716
  76. 76. Hirota Y, Daikoku T, Tranguch S, Xie H, Bradshaw HB, Dey SK. Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. J Clin Invest. 2010;120: 803–815. doi: 10.1172/JCI40051. pmid:20124728
  77. 77. Kagan VE, Kuzmenko AI, Tyurina YY, Shvedova AA, Matsura T, Yalowich JC. Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 Cells: role of myeloperoxidase. Cancer Res. 2001;61: 7777–7784. pmid:11691792
  78. 78. Tyurina YY, Serinkan FB, Tyurin VA, Kini V, Yalowich JC, Schroit AJ, et al. Lipid antioxidant, etoposide, inhibits phosphatidylserine externalization and macrophage clearance of apoptotic cells by preventing phosphatidylserine oxidation. J Biol Chem. 2004;279: 6056–6064. doi: 10.1074/jbc.M309929200. pmid:14630936
  79. 79. Freund A, Patil CK, Campisi J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. Nature Publishing Group; 2011;30: 1536–1548. doi: 10.1038/emboj.2011.69.
  80. 80. Aoshiba K, Tsuji T, Kameyama S, Itoh M, Semba S, Yamaguchi K, et al. Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury. Exp Toxicol Pathol. Elsevier GmbH.; 2013;65: 1053–1062. doi: 10.1016/j.etp.2013.04.001. pmid:23688655
  81. 81. Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75: 50–83. doi: 10.1128/MMBR.00031-10. pmid:21372320
  82. 82. Xu Y, Li N, Xiang R, Sun P. Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci. 2014;39: 268–276. doi: 10.1016/j.tibs.2014.04.004. pmid:24818748
  83. 83. Lappas M, Riley C, Lim R, Barker G, Rice GE, Menon R, et al. MAPK and AP-1 proteins are increased in term pre-labour fetal membranes overlying the cervix: regulation of enzymes involved in the degradation of fetal membranes. Placenta. 2011;32: 1016–1025. doi: 10.1016/j.placenta.2011.09.011. pmid:21963187
  84. 84. Cao Z, Huang CC, Tan W. Nuclease resistance of telomere-like oligonucleotides monitored in live cells by fluorescence anisotropy imaging. Anal Chem. 2006;78: 1478–1484. doi: 10.1021/ac0517601. pmid:16503597
  85. 85. Ermakov A V, Konkova MS, Kostyuk S V, Izevskaya VL, Baranova A, Veiko NN. Oxidized extracellular DNA as a stress signal in human cells. Oxid Med Cell Longev. 2013;2013: 649747. doi: 10.1155/2013/649747. pmid:23533696
  86. 86. Kostjuk S, Loseva P, Chvartatskaya O, Ershova E, Smirnova T, Malinovskaya E, et al. Extracellular GC-rich DNA activates TLR9-and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs). Expert Opin Biol Ther. 2012;12: S99–S111. doi: 10.1517/14712598.2012.690028. pmid:22594608